Cargando…
Prostate cancer vaccines: Update on clinical development
Prostate cancer is a common malignancy among elderly men and is essentially incurable once it becomes metastatic. Results from clinical trials testing a panel of specific vaccines in patients with castration-resistant prostate cancer (CRPC) suggest that alternative therapies may one day substitute o...
Autores principales: | Geary, Sean M., Salem, Aliasger K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667918/ https://www.ncbi.nlm.nih.gov/pubmed/23762812 http://dx.doi.org/10.4161/onci.24523 |
Ejemplares similares
-
Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
por: Tambunlertchai, Supreeda, et al.
Publicado: (2022) -
Potential Role of Selenium in the Treatment of Cancer and Viral Infections
por: Rataan, Aseel O., et al.
Publicado: (2022) -
Implications of current and future approaches to coronavirus disease 2019 testing
por: Smith, Rasheid, et al.
Publicado: (2020) -
The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
por: Geary, Sean M., et al.
Publicado: (2013) -
Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
por: Smith, Rasheid, et al.
Publicado: (2022)